-
Product Insights
Cyclic GMP-AMP Synthase – Drugs In Development, 2023
Global Markets Direct’s Cyclic GMP-AMP Synthase provides in depth analysis on Cyclic GMP-AMP Synthase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Cyclic GMP-AMP Synthase targeted therapeutics...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ustekinumab Biosimilar in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ustekinumab Biosimilar in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ustekinumab Biosimilar in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Golimumab Biosimilar in Inflammation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golimumab Biosimilar in Inflammation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Golimumab Biosimilar in Inflammation Drug Details:Monoclonal antibody is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Golimumab Biosimilar in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golimumab Biosimilar in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Golimumab Biosimilar in Rheumatoid ArthritisDrug Details:Monoclonal antibody is under development for the...
-
Product Insights
GMP Grp/ Trinseo – Polystyrene Recycling Plant – Netherlands
Equip yourself with the essential tools needed to make informed and profitable decisions with our GMP Grp/ Trinseo - Polystyrene Recycling Plant - Netherlands report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Sector Analysis
United States (US) Renewable Energy Policy Handbook, 2023 Update
"United States (US) Renewable Energy Policy Handbook, 2023 Update” is among the latest country specific policy reports from GlobalData, the industry analysis specialist. The report offers comprehensive information on major policies governing the renewable energy market in the country and provides information on renewable policies/developments at a regional/municipal level. The report discusses renewable energy targets and plans along with the present policy framework, giving a fair idea of overall growth potential of the renewable energy industry. The report also provides...
-
Company Profile
Fusion Pharmaceuticals Inc – Company Profile
Fusion Pharmaceuticals Inc (Fusion Pharmaceuticals) is a clinical-stage biopharmaceutical company which develops targeted alpha-particle radio therapeutics for the treatment of cancers. It offers pipeline products such as FPI-1434, FPI-2059 and FPI-1966. The company’s pipeline products treat multiple cancers like head and neck bladder cancer, colorectal cancer and gastric cancers. It aslo include mono therapy and combination therapy. Fusion Pharmaceuticals carters its products under brand Keytruda. It has its operations in the US and Canada. Fusion Pharmaceuticals is headquartered in Hamilton,...
Add to Basket -
Company Profile
Sopharma AD – Company Profile
Sopharma AD (Sopharma) develops, manufactures and markets advanced hearing care solutions. Its major products include behind-the-ear (BTE), receiver-in-canal (RIC), and custom in-the-ear (ITE) hearing instruments; cochlear implants; hearing protection products; FM systems; miniaturized wireless communication systems; and invisible extended-wear hearing instruments. It offers hearing solutions to adults and children with significant hearing loss through its channel partners. Sonova Group offers products under Phonak, Unitron, Advanced Bionics, AudioNova, Sennheiser and Hansaton brands amongst others. The company operates along with subsidiaries and...
Add to Basket -
Company Profile
Bio-Techne Corp – Company Profile
Bio-Techne Corp (Bio-Techne) manufactures, develops and markets biotechnology products and scientific tools to understand biological processes and drive research. The company’s product portfolio includes ELISA kits, ELISpot kits, enzymes, Luminex assays, proteins, GMP products and instruments. Its custom service offerings comprise antibody services, targeted protein degradation services, licensing, cell and gene therapy services, compound library services, ELISA services and gene engineering services. Bio-Techne conducts research in the areas of cancer, cardiovascular, cell and gene therapy, COVID-19, glycobiology, immunology, immuno-oncology, metabolism,...
Add to Basket -
Company Profile
Tilray Inc – Company Profile
Tilray Brands Inc (Tilray) is a pharmaceutical company that focuses on cannabis research, processing, cultivation, and distribution. The company is a Good Manufacturing Practice (GMP) certified company that produces and supplies adult-use cannabis products, medicinal cannabis products, and hemp products among others. Tilray cultivates a wide range of strains including hemp foods and cannabidiol-rich varieties. The company operates under the brand Tilray. It operates through subsidiaries present in Australia, Canada, Chile, France, New Zealand, Portugal, Ireland, Japan, the Netherlands and...
Add to Basket